Are These Stocks Worth A Second Look? Amicus Therapeutics Inc (FOLD), CTI BioPharma Corp (CTIC) and CNO Financial Group Inc (CNO)
New York, NY – GDP INSIDER – 04/23/2014.
This article discusses three companies: Amicus Therapeutics Inc (NASDAQ:FOLD), CTI BioPharma Corp (NASDAQ:CTIC) and CNO Financial Group Inc (NYSE:CNO)
Amicus Therapeutics Inc (NASDAQ:FOLD) suffered a decline of $0.35 or 2.84% to move to a closing price of $11.97 on light trading volume of 0.839 million, compared to its three month average trading volume of 1.77 million The biopharmaceutical company specialized in small molecule treatments has gained 536.70% over the last 52 weeks, far outstripping the performance of the S&P 500 which has only gained 12.40% for the same period. With RSI of 60.46 the stock can still go either way and if Amicus Therapeutics Inc can produce positive news, then the stock could go higher, hold with a view to buy.
CTI BioPharma Corp (NASDAQ:CTIC) began to bounce back yesterday with the stock closing up 4.89% or $0.09 to close at $1.93 on light trading volume of 2.051 million, compared to its three month average trading volume of 3.51 million. The developer and distributor of cancer treatments is still trying to recover from the massive decline in its stock price in the middle of March, after it released the test results for its new myelofibrosis drug Pacritinib, which were not well received by experts in the industry. With RSI now at 47.75 and one year target price estimate of $5.63, it is better to hold than sell for now.
CNO Financial Group Inc (NYSE:CNO) continued its recent upward trend with the stock climbing 0.39% or $0.07 to finish the day at a closing price of $17.99 on higher than average trading volume of 2.204 million, compared to its three month average trading volume of 1.77 million. The $3.58 billion market cap company, which has been oscillating between $14.84 and $18.34 over the past 52 weeks, is currently holding well above its 50 day moving average of $17.06 and 200 day moving average of $16.91. With the stock now outperforming the S&P 500 with a gain of 4.47% so far this year, versus the index which has only increased 2.38%, it is a reasonable hold rather than a buy for the medium term.
About Ultimate Stock Alerts
UltimateStockAlerts.com covers NASDAQ and NYSE listed companies that are overlooked by Wall Street. Investors can choose to receive trading strategies via text message (SMS) or email. To receive free text message alerts text the word ULTIMATE to 555888 from your cell phone. For more information visit www.UltimateStockAlerts.com
Disclosure: UltimateStockAlerts.com is not a registered investment adviser and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit www.UltimateStockAlerts.com website, for complete risks and disclosures.